Cangene Corporation, a biopharmaceutical company focused on speciality plasma products, has appointed John Sedor president and chief executive officer, and a member of the board of directors. Mr Sedor
Biotech executives make strategic decisions based on incentives that aren't necessarily aligned to benefit either the company's investors or employees. Three modifications to business as usual would h
Shares in the diversified Japanese textiles and materials group Toray Industries jumped by 10% during trading in Tokyo on August 13th, following reports that the company is developing an inhaled insul